News

Samsung has announced plans to introduce its first AI smart glasses, marking its entry into the growing AI wearable devices market. The upcoming device will feature an eye-level camera and rely on a connected smartphone for processing to keep the glasses lightweight. Developed alongside Qualcomm and Google, the product is expected to integrate with Samsung’s Galaxy ecosystem and deliver hand [...]

Walmart is rolling out digital shelf labels across all its U.S. stores following a successful pilot in 2,300 locations. The technology enables instant price updates, reduces manual labor, and improves online order picking through pick-to-light functionality. By replacing paper labels with automated electronic tags, the retailer aims to enhance operational efficiency, improve customer experience, a [...]

The Coca‑Cola Company reported its fourth-quarter 2025 financial results with profits exceeding analyst expectations despite a slight revenue miss. The company recorded net revenue of $11.82 billion, reflecting modest year-over-year growth while facing weaker demand in developed markets.html,body,body:not(.web_whatsapp_com) *,html body:not(.web_whatsapp_com) *,html body.ds *,html body:not(.web_w [...]

Tate & Lyle and Manus Bio have introduced Yume M Stevia under The Sweetener Alliance, marking a major innovation in sugar reduction. Produced in the U.S. using advanced bioconversion technology, this next-generation Stevia sweetener offers clean taste, traceability, and sustainability for health-focused food and beverage brands. [...]

Eisai, in collaboration with leading kidney cancer advocacy groups, has launched Kompass, a digital platform designed to guide patients and caregivers through every stage of the kidney cancer journey. The site centralizes trusted resources, support tools, and educational content to help users make informed health decisions with confidence. [...]

GSK has agreed to acquire Canadian biotech 35Pharma Inc. for $950 million, gaining full rights to HS235, a novel PAH therapy candidate.  [...]

The U.S. Food and Drug Administration (FDA) has fully approved encorafenib in combination with cetuximab and fluorouracil-based chemotherapy for adults with BRAF V600E-mutated metastatic colorectal cancer. The approval, supported by the Phase 3 BREAKWATER, nearly doubles overall survival and confirms the therapy’s clinical benefit as a first-line targeted treatment option. [...]

Astellas and Vir Biotechnology have teamed up to accelerate VIR-5500 development — a next-gen PSMA-targeting PRO XTEN® therapy for metastatic prostate cancer.  [...]

The FDA has approved ADQUEY™ (difamilast 1%) ointment, a non-steroidal PDE4 inhibitor for treating mild-to-moderate atopic dermatitis in adults and children aged two and older. [...]

CUBE has acquired Silicon Valley-based 4CRisk.ai to strengthen its AI-driven compliance and risk automation platform. The integration will enable organisations to connect regulatory updates directly to internal governance, policy, and risk frameworks across global markets. [...]